GSK plc (GSK) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à Brentford, United Kingdom. Le PDG actuel est Luke Victor Miels.
GSK a date d'introduction en bourse 1980-03-28, 68,629 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $118.67B.
GSK plc is a global pharmaceutical and vaccine company headquartered in Brentford, United Kingdom, engaged in the research, development, and manufacture of vaccines and specialty medicines. The company's portfolio includes vaccines for shingles, meningitis, respiratory syncytial virus, influenza, and polio, as well as medicines for HIV, oncology, respiratory and immunology conditions, and antibiotics. GSK operates through Commercial Operations and Total R&D segments, serving markets across the United Kingdom, United States, and internationally. The company has established multiple strategic collaborations, including partnerships with CureVac for mRNA-based influenza vaccines, Wave Life Sciences for oligonucleotide platform development, and Flagship Pioneering for novel medicines and vaccines discovery. Founded in 1715 and rebranded as GSK plc in 2022, the company remains a leading player in global healthcare innovation.
